"Marshfield Clinic Cancer Center - Eau Claire is a specialized medical group dedicated to the diagnosis and treatment of various cancer and many blood disorders. On-site staff includes board-certified hematologists and oncologists, oncology-certified nurses (OCN), pharmacists, oncology social worker, a financial assistance coordinator, patient navigator and medical assistants."

During the past decade, Marshfield Medical Center-EC Cancer Center conducted 153 clinical trials. In the 10-year time frame, 153 clinical trials started and 63 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 74 clinical trials started and 30 clinical trials were completed. i.e. 40.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marshfield Medical Center-EC Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 64 trials, followed by "Alliance for Clinical Trials in Oncology" with 51 trials sponsored, "SWOG Cancer Research Network" with 34 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored and "Eastern Cooperative Oncology Group" with 26 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marshfield Medical Center-EC Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 151 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Marshfield Medical Center-EC Cancer Center" are "Breast Cancer" (14 trials), "Leukemia" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Colorectal Cancer" (7 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (7 trials). Many other conditions were trialed in "Marshfield Medical Center-EC Cancer Center" in a lesser frequency.

Most popular intervention types in "Marshfield Medical Center-EC Cancer Center" are "Drug" (157 trials), "Other" (119 trials), "Biological" (80 trials), "Procedure" (66 trials) and "Radiation" (38 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (47 trials), "Questionnaire Administration" (34 trials), "Biospecimen Collection" (30 trials), "Computed Tomography" (30 trials) and "Laboratory Biomarker Analysis" (28 trials). Other intervention names were less common.

The vast majority of trials in "Marshfield Medical Center-EC Cancer Center" are 179 trials for "All" genders, 27 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Marshfield Medical Center-EC Cancer Center". undefined are not yet recruiting, 74 are recruiting, 74 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Marshfield Medical Center-EC Cancer Center, 6 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Marshfield Medical Center-EC Cancer Center, 4 "Phase 1" clinical trials were conducted, 93 "Phase 2" clinical trials and 108 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".